<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="Choi, MD, PhD. Division of Pediatric Cardiology, Department of Pediatrics," exact="Yonsei University" post="College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea."/>
 <result pre="≥25 mm) underwent device closure with Amplatzer septal occluder (ASO;" exact="St. Jude Medical" post="Inc., Plymouth, MN, USA) were included in this study."/>
 <result pre="one patient. Peri-procedural transthoracic echocardiography TTE was routinely performed using" exact="Philips" post="® iE33 echocardiography equipment (Philips, Amsterdam, The Netherlands). The"/>
 <result pre="size. Right ventricular size and function were assessed to the" exact="American Society of Echocardiography." post="10) Right ventricular systolic pressure was estimated using the"/>
 <result pre="15.3 (27 of 176) in large ASD groups for TEE," exact="Philips" post="® echocardiography equipment (Philips) was used. All echocardiographic examinations"/>
 <result pre="echocardiographic examinations were performed according to the recommendations of the" exact="American Society of Echocardiography." post="11) ICE guidance After June 2006, ASD closure was"/>
 <result pre="intervention in pediatric cardiac disease: a scientific statement from the" exact="American Heart Association" post="Circulation 2011 123 2607 2652 21536996 6 Kazmouz S"/>
</results>
